New scan may sharpen radiation targeting for brain cancer patients
NCT ID NCT02104310
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a special PET scan (18F-DOPA) to the standard MRI can help doctors better plan radiation treatment for people with certain brain tumors (malignant glioma). The PET scan may show tumor tissue more clearly than MRI alone. About 25 participants aged 7 and older with grade II or III glioma will be enrolled. The goal is to compare treatment areas defined by MRI versus MRI plus the PET scan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal fluid DNA test could personalize brain cancer therapy
- Experimental vaccine aims to rally immune system against recurrent brain cancer
- Immunotherapy drug nivolumab tested in young brain cancer patients
- Brain Tumor's hidden electrical signals could reveal its weaknesses
- New hope for aggressive brain tumors? early trial combines two targeted drugs
- Supercharged immune cells take on deadly brain tumors